Home » Topics » Regulatory » Patents

Patents
RSS

Chinese organizations patent new anticancer agents

Dec. 14, 2011

Novel serine/threonine-protein kinase ATR inhibitors prepared by Vertex

Dec. 14, 2011

New phosphodiesterase 10A inhibitors claimed

Dec. 14, 2011

Medical Research Council Technology patents novel protein kinase inhibitors

Dec. 13, 2011

Novel phosphodiesterase 10A inhibitors synthesized by Amgen

Dec. 13, 2011

Sanofi discloses new histamine H3 receptor inverse agonists

Dec. 13, 2011

Nissan Chemical presents novel adiponectin receptor protein 1 agonists

Dec. 12, 2011

Merck & Co. discovers new PRCP inhibitors

Dec. 12, 2011

Novel lysophospholipid S1P1 receptor modulators characterized at Allergan

Dec. 12, 2011

Amgen describes new ALK tyrosine kinase receptor inhibitors

Dec. 12, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...